Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

AIMS: Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF). Many AHF patients have preserved ejection fraction (HFpEF). Given the lack of evidence-based therapies in this population, we evaluated the effects of serelaxin according to EF in RELAX-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Teerlink, John R., Farmakis, Dimitrios, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Greenberg, Barry H., Hua, Tsushung, Ponikowski, Piotr, Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Metra, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
FASTTrack Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992428/
https://www.ncbi.nlm.nih.gov/pubmed/24316514
http://dx.doi.org/10.1093/eurheartj/eht497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992428/
https://www.ncbi.nlm.nih.gov/pubmed/24316514
http://dx.doi.org/10.1093/eurheartj/eht497

Ejemplares similares